Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.05 - $24.02 $10,830 - $14,412
-600 Reduced 3.0%
19,400 $359,000
Q2 2024

Aug 14, 2024

SELL
$18.65 - $28.5 $59,679 - $91,200
-3,200 Reduced 13.79%
20,000 $386,000
Q1 2024

May 15, 2024

SELL
$24.74 - $35.13 $267,192 - $379,404
-10,800 Reduced 31.76%
23,200 $626,000
Q4 2023

Feb 14, 2024

BUY
$21.62 - $37.21 $179,446 - $308,843
8,300 Added 32.3%
34,000 $1.22 Million
Q3 2023

Nov 15, 2023

BUY
$27.34 - $55.37 $139,434 - $282,387
5,100 Added 24.76%
25,700 $726,000
Q2 2023

Aug 23, 2023

BUY
$26.1 - $49.92 $41,760 - $79,872
1,600 Added 8.42%
20,600 $1.03 Million
Q1 2023

May 15, 2023

SELL
$18.09 - $27.61 $41,607 - $63,503
-2,300 Reduced 10.8%
19,000 $477,000
Q4 2022

Feb 14, 2023

SELL
$16.24 - $26.38 $201,375 - $327,112
-12,400 Reduced 36.8%
21,300 $398,000
Q3 2022

Nov 14, 2022

SELL
$23.95 - $34.71 $7,185 - $10,413
-300 Reduced 0.88%
33,700 $850,000
Q2 2022

Aug 15, 2022

SELL
$21.39 - $35.9 $1.42 Million - $2.39 Million
-66,500 Reduced 66.17%
34,000 $937,000
Q1 2022

May 16, 2022

BUY
$24.84 - $36.12 $722,844 - $1.05 Million
29,100 Added 40.76%
100,500 $3.45 Million
Q4 2021

Feb 14, 2022

SELL
$33.38 - $59.25 $540,756 - $959,850
-16,200 Reduced 18.49%
71,400 $2.46 Million
Q3 2021

Nov 12, 2021

BUY
$53.75 - $76.55 $1.91 Million - $2.72 Million
35,500 Added 68.14%
87,600 $4.79 Million
Q2 2021

Aug 06, 2021

BUY
$59.02 - $78.8 $1.47 Million - $1.96 Million
24,900 Added 91.54%
52,100 $4.05 Million
Q1 2021

May 14, 2021

SELL
$64.61 - $113.09 $161,525 - $282,725
-2,500 Reduced 8.42%
27,200 $1.96 Million
Q4 2020

Feb 12, 2021

BUY
$48.06 - $84.4 $221,076 - $388,240
4,600 Added 18.33%
29,700 $2.43 Million
Q3 2020

Nov 13, 2020

BUY
$46.87 - $93.33 $1.18 Million - $2.34 Million
25,100 New
25,100 $1.19 Million

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.22B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.